Drug Side Effects

INTESTINAL SEPSIS

This adverse event was reported 170 times

These drugs are most commonly taken by patients reporting INTESTINAL SEPSIS:

# Drug Count
0 ADALIMUMAB 98
1 ETANERCEPT 68
2 RITUXIMAB 68
3 ABATACEPT 67
4 TOCILIZUMAB 67
5 INFLIXIMAB 66
6 METHOTREXATE SODIUM 66
7 LEFLUNOMIDE 65
8 SULFASALAZINE 65
9 TOFACITINIB 63
See all common drugs associated with INTESTINAL SEPSIS

INTESTINAL SEPSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GOLD 42 0.0106
1 CANAKINUMAB 41 0.0051
2 MINOCYCLINE HYDROCHLORIDE 40 0.0037
3 ANAKINRA 42 0.0036
4 ACETYLSALICYCLIC ACID 1 0.0034
5 DOXYCLYCLINE HYCLATE 17 0.0017
6 DAUNORUBICIN HYDROCHLORIDE 1 0.0011
7 SULFASALAZINE 65 0.0011
8 TOCILIZUMAB 67 0.0008
9 HYDROXYCHLOROQUINE SULFATE 60 0.0008
See all drugs enriched for association with INTESTINAL SEPSIS

These drug classes are most commonly taken by patients reporting INTESTINAL SEPSIS:

# Drug class Count
0 CD20-directed Cytolytic Antibody [EPC] 69
1 Tumor Necrosis Factor Blocker [EPC] 69
2 Interleukin-6 Receptor Antagonist [EPC] 67
3 Selective T Cell Costimulation Modulator [EPC] 67
4 Aminosalicylate [EPC] 65
5 Antirheumatic Agent [EPC] 65
6 Folate Analog Metabolic Inhibitor [EPC] 62
7 Interleukin-1 Receptor Antagonist [EPC] 42
8 Standardized Chemical Allergen [EPC] 42
9 Opioid Agonist [EPC] 40
See all common drug classes associated with INTESTINAL SEPSIS

INTESTINAL SEPSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 42 0.0036
1 Standardized Chemical Allergen [EPC] 42 0.0034
2 Antirheumatic Agent [EPC] 65 0.0008
3 Interleukin-6 Receptor Antagonist [EPC] 67 0.0008
4 Aminosalicylate [EPC] 65 0.0007
5 Selective T Cell Costimulation Modulator [EPC] 67 0.0007
6 Tetracycline-class Drug [EPC] 24 0.0005
7 CD20-directed Cytolytic Antibody [EPC] 69 0.0004
8 Anticholinergic [EPC] 3 0.0003
9 GLP-2 Analog [EPC] 2 0.0002
See all drug classes enriched for association with INTESTINAL SEPSIS